Carmustine and the lungs

Lancet

Volumn 349, Issue 9067, 1997, Pages 1712-1713

  Schmitz, N ^a   Diehl, V ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; NITROSOUREA DERIVATIVE;

HUMAN; LUNG INJURY; LUNG TOXICITY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030904735     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)62951-0     Document Type: Note

References (7)

1. PV Iriarte J Hananian JA Cortner Central nervous system leukemia and solid tumors of childhood. Treatment with 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) Cancer 19 1966 1187 1194
2. JG Clark JA Hansen MI Hertz Idiopathic pneumonia syndrome after bone marrow transplantation Am Rev Respir Dis 147 1993 1601 1606
3. PA Aronin MS Mahaley SA Rudnick Prediction of BCNU pulmonary toxicity in patients with malignant gliomas. An assessment of risk factors N Engl J Med 303 1980 183 188
4. BR O'Driscoll PS Hasleton FRC Path Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood N Engl J Med 323 1990 378 382
5. C Wheeler JH Antin WH Churchill Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lyphoma: A dose-finding study J Clin Oncol 8 1990 648 656
6. C Rubio NE Hill S Milan Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease Br J Cancer 75 1997 1044 1048
7. SI Bearman FR Appelbaum CD Buckner Regimen-related toxicity in patients undergoing bone marrow transplantation J Clin Oncol 6 1988 1562 1568